Analisis Cakupan Obat Massal Pencegahan Filariasis Di Kabupaten Bandung Dengan Pendekatan Model Sistem Dinamik
<pre style="text-align: justify;"><em><span style="font-size: 12.0pt; font-family: "Times New Roman",serif;" lang="EN-US">Filariasis Preventive Mass Drug Administration (MDA) program supposed to covered at least 65% of the target. Acc...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Balai Litbang P2B2 Banjarnegara
2016-07-01
|
Series: | Balaba: Jurnal Litbang Pengendalian Penyakit Bersumber Binatang Banjarnegara |
Subjects: | |
Online Access: | http://ejournal.litbang.kemkes.go.id/index.php/blb/article/view/4470 |
Summary: | <pre style="text-align: justify;"><em><span style="font-size: 12.0pt; font-family: "Times New Roman",serif;" lang="EN-US">Filariasis Preventive Mass Drug Administration (MDA) program supposed to covered at least 65% of the target. According to the Indonesia’s program annual reports, the coverage from year of 2005-2009 are 28%-29%.</span></em><em><span style="font-size: 11.0pt; font-family: "Times New Roman",serif;" lang="EN-US"> Those coverage are still far below the expected coverage. </span></em><em><span style="font-size: 11.0pt; font-family: "Times New Roman",serif; mso-ansi-language: EN;" lang="EN">Bandung Regency is one of 11 filariasis endemic areas in West Java that treatment coverage for four years (2009-2012) in a row is 70%, 62%, 64% and 68%. This study was an observational study with cross sectional study design studies. The study was conducted at the health center Cikaro Regency Bandung in 2013 to determine the variable leverage increase treatment coverage. The data collected in this study include primary data and secondary data. The primary data obtained through interviews of 200 respondents to the questionnaire and also through Focus Group Discussion (FGD). Secondary data include population and filariasis treatment coverage of data obtained from the agency terkait.Variabel levers determined through the analysis of dynamic system modeling software powersim. The results showed that the variable lever to increase the coverage of treatment is to reduce the negative impact of drug side effects, increasing the number of cadres and knowledge as well as increased monitoring activities of treatment. Increased treatment coverage can be done through the declaration take medicine in the empowering cadres.</span></em></pre><div id="_mcePaste" class="mcePaste" style="position: absolute; left: -10000px; top: 0px; width: 1px; height: 1px; overflow: hidden;"><pre style="text-align: justify;"><em><span style="font-size: 12.0pt; font-family: "Times New Roman",serif;" lang="EN-US">Filariasis Preventive Mass Drug Administration (MDA) program supposed to covered at least 65% of the target. According to the Indonesia’s program annual reports, the coverage from year of 2005-2009 are 28%-29%.</span></em><em><span style="font-size: 11.0pt; font-family: "Times New Roman",serif;" lang="EN-US"> Those coverage are still far below the expected coverage. </span></em><em><span style="font-size: 11.0pt; font-family: "Times New Roman",serif; mso-ansi-language: EN;" lang="EN">Bandung Regency is one of 11 filariasis endemic areas in West Java that treatment coverage for four years (2009-2012) in a row is 70%, 62%, 64% and 68%. This study was an observational study with cross sectional study design studies. The study was conducted at the health center Cikaro Regency Bandung in 2013 to determine the variable leverage increase treatment coverage. The data collected in this study include primary data and secondary data. The primary data obtained through interviews of 200 respondents to the questionnaire and also through Focus Group Discussion (FGD). Secondary data include population and filariasis treatment coverage of data obtained from the agency terkait.Variabel levers determined through the analysis of dynamic system modeling software powersim. The results showed that the variable lever to increase the coverage of treatment is to reduce the negative impact of drug side effects, increasing the number of cadres and knowledge as well as increased monitoring activities of treatment. Increased treatment coverage can be done through the declaration take medicine in the empowering cadres.</span></em></pre></div> |
---|---|
ISSN: | 1858-0882 2338-9982 |